Cargando…

Perspectives on the therapeutic potential of MDMA: A nation-wide exploratory survey among substance users

BACKGROUND: Alcohol and other substance use disorders are commonly associated with post-traumatic stress disorder (PTSD), and the presence of these comorbidities is associated with worse treatment outcomes. Additionally, disparities in substance and PTSD prevalence have been associated with minority...

Descripción completa

Detalles Bibliográficos
Autor principal:	Jones, Jennifer L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140372/ https://www.ncbi.nlm.nih.gov/pubmed/37124269 http://dx.doi.org/10.3389/fpsyt.2023.1096298

Ejemplares similares

Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database
por: Makunts, Tigran, et al.
Publicado: (2022)

MDMA for the treatment of misophonia, a proposal
por: Webb, Jadon, et al.
Publicado: (2022)

A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy
por: Sottile, Robert J., et al.
Publicado: (2022)

Concomitant medications associated with ischemic, hypertensive, and arrhythmic events in MDMA users in FDA adverse event reporting system
por: Makunts, Tigran, et al.
Publicado: (2023)

Analysis of factors influencing substance use craving among Chinese substance users
por: Guo, Huijuan, et al.
Publicado: (2022)

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
por: Sessa, Ben, et al.
Publicado: (2019)

No Influence of Dopamine System Gene Variations on Acute Effects of MDMA
por: Vizeli, Patrick, et al.
Publicado: (2019)

Attenuated Psychotic Symptoms in Adolescents With Chronic Cannabis and MDMA Use
por: Wiedmann, Melina, et al.
Publicado: (2022)

Relational and Growth Outcomes Following Couples Therapy With MDMA for PTSD
por: Wagner, Anne C., et al.
Publicado: (2021)

Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems
por: Argento, Elena, et al.
Publicado: (2021)

MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder
por: Christie, Devon, et al.
Publicado: (2022)

3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review
por: Inouye, Ann, et al.
Publicado: (2022)

Crime and Violence among MDMA Users in the United States
por: Vaughn, Michael G., et al.
Publicado: (2015)

“Hot” and “Cold” Cognition in Users of Club Drugs/Novel Psychoactive Substances
por: Savulich, George, et al.
Publicado: (2021)

Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline
por: Feduccia, Allison A., et al.
Publicado: (2019)

Social anxiety and MDMA-assisted therapy investigation: a novel clinical trial protocol
por: Lear, M. Kati, et al.
Publicado: (2023)

Latent Classes of Substance Use in Adolescent Cannabis Users: Predictors and Subsequent Substance-Related Harm
por: Fallu, Jean-Sébastien, et al.
Publicado: (2014)

MDMA-assisted psychotherapy; Inclusion of transgender and gender diverse people in the frontiers of PTSD treatment trials
por: Stauffer, Christopher S., et al.
Publicado: (2022)

Detecting Suicide and Self-Harm Discussions Among Opioid Substance Users on Instagram Using Machine Learning
por: Purushothaman, Vidya, et al.
Publicado: (2021)

Investigating predictors of problematic alcohol, cannabis, and nicotine use among legal users of all three substances
por: Shephard, Aaron, et al.
Publicado: (2023)

Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder
por: Singleton, S. Parker, et al.
Publicado: (2023)

Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study
por: Więckiewicz, Gniewko, et al.
Publicado: (2023)

Perceptions of prevalence, consequences, and strategies for managing contraband substance use in an inpatient concurrent disorders program: A qualitative study of patient perspectives and survey of clinician perspectives
por: Rahman, Liah, et al.
Publicado: (2022)

Study protocol for “MDMA-assisted therapy as a treatment for major depressive disorder: A proof of principle study”
por: Kvam, Tor-Morten, et al.
Publicado: (2022)

The Influence of Genetic and Environmental Factors among MDMA Users in Cognitive Performance
por: Cuyàs, Elisabet, et al.
Publicado: (2011)

Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders
por: Oehen, Peter, et al.
Publicado: (2022)

Facing death, returning to life: A qualitative analysis of MDMA-assisted therapy for anxiety associated with life-threatening illness
por: Barone, William, et al.
Publicado: (2022)

Substance Dependence Among Bipolar, Unipolar Depression and Psychotic Homeless: A Canadian National Study
por: Maremmani, Angelo G. I., et al.
Publicado: (2018)

Avoiding Emotional Bonds: An Examination of the Dimensions of Therapeutic Alliance Among Cannabis Users
por: Healey, Alison, et al.
Publicado: (2013)

Perceived key change phenomena of MDMA-assisted psychotherapy for the treatment of severe PTSD: an interpretative phenomenological analysis of clinical integration sessions
por: Godes, Macha, et al.
Publicado: (2023)

MDMA-Assisted Therapy as a Means to Alter Affective, Cognitive, Behavioral, and Neurological Systems Underlying Social Dysfunction in Social Anxiety Disorder
por: Luoma, Jason, et al.
Publicado: (2021)

Psychopathological Burden and Quality of Life in Substance Users During the COVID-19 Lockdown Period in Italy
por: Martinotti, Giovanni, et al.
Publicado: (2020)

Potential Psychiatric Uses for MDMA
por: Yazar‐Klosinski, BB, et al.
Publicado: (2017)

Does Gender Moderate the Relationship Between Chronic Pain and Substance Use Disorder? Insights From a National Canadian Population Survey
por: Su, Yingying, et al.
Publicado: (2022)

Current Trends and Perspectives in the Immune Therapy for Substance Use Disorders
por: Vasiliu, Octavian
Publicado: (2022)

Attachment and Therapeutic Alliance in Substance Use Disorders: Initial Findings for Treatment in the Therapeutic Community
por: Rübig, Leonie L., et al.
Publicado: (2021)

Psychometric evaluation of PHQ–9 and GAD–7 among community health volunteers and nurses/midwives in Kenya following a nation-wide telephonic survey
por: Odero, Sabina Adhiambo, et al.
Publicado: (2023)

Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges
por: Barnett, Brian S., et al.
Publicado: (2023)

Decision-Making Under Risk, but Not Under Ambiguity, Predicts Pathological Gambling in Discrete Types of Abstinent Substance Users
por: Wilson, Michael J., et al.
Publicado: (2018)

Corrigendum: Psychometric evaluation of PHQ-9 and GAD-7 among community health volunteers and nurses/midwives in Kenya following a nation-wide telephonic survey
por: Odero, Sabina Adhiambo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q461i5ikmgetaatbthuou7bpnn